Actively Recruiting
Neurologic Stem Cell Treatment Study
Led by MD Stem Cells · Updated on 2025-06-06
500
Participants Needed
3
Research Sites
582 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/
CONDITIONS
Official Title
Neurologic Stem Cell Treatment Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have documented functional damage to the central or peripheral nervous system unlikely to improve with present standard of care.
- Be at least 6 months post-onset of the disease.
- If under current medical therapy (pharmacologic or surgical treatment) for the condition be considered stable on that treatment and unlikely to have reversal of the associated neurologic functional damage as a result of the ongoing pharmacologic or surgical treatment.
- In the estimation of Dr. Weiss and the neurologists have the potential for improvement with BMSC treatment and be at minimal risk of any potential harm from the procedure.
- Be over the age of 18 and capable of providing informed consent.
- Be medically stable and able to be medically cleared by their primary care physician or a licensed primary care practitioner for the procedure.
You will not qualify if you...
- Patients must be capable of an adequate neurologic examination and evaluation to document the pathology and cooperate with the exam.
- Patients must be capable and willing to undergo follow-up neurologic exams with the study team or their own neurologists.
- Patients must be capable of providing informed consent.
- In the estimation of Dr. Weiss, the BMSC collection and treatment should not present significant risk of harm to the patient's general health or neurologic function.
- Patients who are not medically stable or who may be at significant risk to their health undergoing the procedure are not eligible.
- Women of childbearing age must not be pregnant at the time of treatment and should avoid becoming pregnant for 3 months after treatment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
MD Stem Cells
Westport, Connecticut, United States, 06880
Actively Recruiting
2
MD Stem Cells
Coral Springs, Florida, United States, 33065
Actively Recruiting
3
The Saudi-German Hospital
Dubai, United Arab Emirates, 337-1500
Actively Recruiting
Research Team
S
Steven Levy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here